Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
1,178,051
-
Shares change
-
+1,177,978
-
Total reported value, excl. options
-
$79,262,795
-
Value change
-
+$79,257,889
-
Number of buys
-
76
-
Price
-
$67.21
Significant Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q2 2018
77 filings reported holding PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS as of Q2 2018.
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,178,051 shares
.
Largest 10 shareholders include Peak Asset Management, LLC (128,708 shares), BANK OF AMERICA CORP /DE/ (101,033 shares), LPL Financial LLC (95,574 shares), MORGAN STANLEY (77,306 shares), UBS Group AG (75,551 shares), AMERIPRISE FINANCIAL INC (66,482 shares), COMMONWEALTH EQUITY SERVICES, LLC (54,586 shares), CIBC Private Wealth Group, LLC (51,200 shares), WELLS FARGO & COMPANY/MN (46,084 shares), and CITADEL ADVISORS LLC (41,549 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.